Back to Stakeholders
Categories

1 domain / 2 areas / 2 specializations

Research, Drug Development & Manufacturing
Pharmaceutical ManufacturingEstablished ManufacturersLab Testing, Quality Control & Production Standards
Research, Drug Development & Manufacturing

Cayman Chemical

Established supplier and CDMO platform (with Cayman Pharma) providing cGMP API manufacturing, including psychedelic compounds for clinical-trial pathways and analytical support.

Manufacturing Snapshot

Established CDMO / Manufacturer

Scope & Capabilities

API ProductionAnalytical / QC TestingCDMO ServicesRegulatory / CMC Support

Supply Use Cases

Clinical TrialsResearch Use

GxP / Compliance

cGMPDEA Controlled-Substance ComplianceISO

Facilities & Access

Combined US and Czech manufacturing footprint via Cayman Chemical and Cayman Pharma.

Capacity Notes

API manufacturing materials describe annual capacity plus scale-up capability for multi-step synthesis programs.

Manufacturing Details

Supported Substances

Cayman API materials cite cGMP psilocybin and psilocin for clinical trials, with development listings including 3,4-MDMA and N,N-DMT.

Manufacturing Sources

Cayman Chemical

https://www.caymanchem.com/

Cayman API Manufacturing Overview

https://cdn2.caymanchem.com/cdn/cms/caymanchem/LiteratureCMS/API%20Manufacturing.pdf

Quick Facts

Website
Visit